Forget GMOs. The next big battle is over genetically ‘edited’ foods

The goal is to avoid the sort of public backlash that rocked Monsanto in the late 1990s and still plagues agriculture two decades later. In the United States,  consumer skepticism of genetically modified crops has forced biotech companies into long, costly battles over issues such as whether these foods should be labeled; elsewhere in the world, the public outcry has prevented seeds from winning government approval. “It’s more about social science than science,” said Neal Gutterson, the vice president of research and development at DuPont Pioneer. “[It’s] ultimately about getting social license for this technology.”Odes to plant technology are ubiquitous in DuPont Pioneer’s Iowa offices, where even the conference space boasts glossy, museum-like exhibits devoted to genetically modified foods. Plus-sized photos show farmers standing idly in golden corn fields, and mystery hands reaching into overflowing bowls.But the problem for DuPont Pioneer, and agribusiness generally, is that large swaths of the public do not share this sunny vision of biotech. Since the late '90s, when Monsanto botched the introduction of genetically modified crops in Europe, consumers have treated the term “GMO” as if it were a dirty word. According to the Pew Research Center, nearly 40 percent of Americans believe GMOs are bad for their health. This assertion is not supported by science, which has concluded that the genetically modified crops on the market are safe for consumption.